Abstract:The success of the drug discovery process is often a function of the diversity of chemotypes examined. Natural products screening represents a potential source of organic chemicals of unparalleled diversity. To effectively realize this potential requires use of a selection strategy tailored to the needs of the individual screening program. Historically, plants and microorganisms have been extraordinarily rich sources of medicinally and agriculturally useful compounds. Interest in these sources of new bioactive molecules continues to the present time. In recent years, the evaluation of insects and marine invertebrates as sources of biologically active compounds has added to the array of new chemotypes. While the efficiencies of modern screening methods allow for the cost effective evaluation of vast numbers of samples, the cost of acquiring and processing natural products, particularly macroorganisms, is substantial relative to other sources of molecular diversity. A successful drug discovery program must then aim to evaluate the broadest diversity of relevant chemical classes in the minimum number of samples and least time. To achieve this goal, a careful assessment must be made of each source of molecular diversity, natural and man-made, and a proper balance of sources established. An evaluation of the ecological/environmental ramifications of collecting organisms from natural populations for screening operations and pre-development studies is an integral part of this assessment. While the screening of natural products, requiring a very small sample, is a practical endeavour, the realities of obtaining sufficient quantities of compound from natural populations of macroorganisms to support product development and eventual sale are often problematic. Alternative methods of producing interesting compounds, including synthesis, cell culture and agriculture, may be required in order to minimize the ecological impact of these discoveries. While our environmental concerns often focus on the direct impact of this research, they extend far beyond the scope of these studies, fostering the preservation and sustainable utilization of the natural habitats of our collaboratoring

Strategies To Diversify Natural Products For Drug Discovery

Integrated Approaches for Discovering Novel Drugs From Microbial Natural Products

A General Strategy for Diversifying Complex Natural Products to Polycyclic Scaffolds with Medium-Sized Rings

Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes

The strategies and techniques of drug discovery from natural products

Use of Natural Products As Chemical Library for Drug Discovery and Network Pharmacology

[Strategies on the Construction of High-Quality Microbial Natural Product Library--a Review].

Molecular Diversity, Biological Diversity and the Search for New Drugs

Recent Advances in Combinatorial Biosynthesis for Drug Discovery.

Combinatorial synthesis of libraries of natural product analogues

The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery.

Late-Stage Diversification of Natural Products

Diversity Oriented Synthesis and Branching Reaction Pathway to Generate Natural Product-Like Compounds

Recent Advances in Divergent Synthetic Strategies for Indole-Based Natural Product Libraries

Using Natural Products for Drug Discovery: the Impact of the Genomics Era

Natural products as drug leads: exploring their potential in drug discovery and development

NATURAL PRODUCTS: FROM TRADITIONAL MEDICINE TO LEAD COMPOUNDS FOR DRUG DEVELOPMENT IN THE 21ST CENTURY

Plant-Derived Natural Products: A Source for Drug Discovery and Development

Lead/Drug Discovery from Natural Resources

Expanding Chemical Frontiers: Approaches for Generating Diverse and Bioactive Natural Product‐Like Compounds Libraries from Extracts

The Structural Modification of Natural Products for Novel Drug Discovery